Ledger.Open graph →
SEC Form D · Amendment · filed November 3, 2023

Elastrin Therapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Greenville, SC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Klaus-Dieter Langner · Grenville, SCDirectorPatrick Burgermeister · Greenville, SCDirectorMatthias Breugelmans · Greenville, SCExec · DirectorNaren Vyavahare · Greenville, SCExec · DirectorKlaus-Dieter Langner · Grenville, SCDirectorNaren Vyavahare · Greenville, SCExec · DirectorMatthias Breugelmans · Greenville, SCExec · DirectorPatrick Burgermeister · Greenville, SCDirectorRichard Scott-Hopkins · George Town, Grand Cayman, Cayman IslandsExec · DirectorJudith J. Lawson · Louisville, CODirectorGeoffrey C. Dietrich · DALLAS, TXExec · DirectorRoo Discovery General Partner, L.P · Coconut Grove, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗